Wynn Pulls Back Market Rotation Hits Real Estate 20260403 1 Charter Communications Announces Enhanced Buyout Agreement for Liberty Broadband SpaceX Starship V3 Test Flight Successfully Launches After Delay US Payrolls Jump More Than Expected but April Report Reveals Red Flags for Economy Healthcare and Tech Rally Push SP 500 to Modest Gain The Boston Beer Company Faces Price Target Reduction on Cost and Macroeconomic Pressures UAE and Iraq Strengthen Pipeline Networks to Reduce Strait of Hormuz Dependence SGHT Q1 2026 Earnings EPS Misses Estimates as Costs Outpace Expectations XMTR Q1 2026 Earnings EPS Beats Estimates by 1385 as Marketplace Momentum Continues Builders FirstSource BLDR Q1 2026 Earnings EPS Misses Estimates Amid Market Challenges PDLB Q4 2025 Earnings Significant EPS Beat Belies Stock Decline SION Q1 2026 Earnings EPS Misses Consensus as PreRevenue Biotech Advances Pipeline Stock Edges Higher QURE Q1 2026 Earnings NarrowerthanExpected Loss Fails to Lift Shares Mondelez International MDLZ Holds Steady Near Support as Consumer Staples Sector Attracts Defensive Flows BT Brands Inc BTBD Edges Higher as Bullish Momentum Tests Key Resistance Alnylam Pharmaceuticals ALNY Holds Near Support Amid Modest Decline ALPS Group Holds Above 070 Support After Modest Uptick LQR House Inc YHC Edges Higher Amid Consolidation at 086 Support and Resistance Remain Key Options Trading Without BlackScholes Chart Analysis as an Alternative Approach Centuri Holdings Inc CTRI Q1 2026 Earnings Narrowing Loss Beats Expectations on Cost Discipline Western Asset Investment Grade Opportunity Trust IGI Holds Steady Near Key Support Resistance Ahead Melar Acquisition Corp I MACI Holds Steady Near 1085 as SPAC Trading Remains Subdued Lifezone Metals LZM Surges Over 8 Testing Key Resistance at 534 Metalla Royalty Streaming MTA Climbs 209 Approaching Key Resistance at 796 Acrivon Therapeutics ACRV Edges Higher Biotech Stock Tests Key Resistance at 177 New England Realty Associates NEN Holds Steady at 60 A RangeBound Resilience Play PIMCO Access Income Fund PAXS Shows Resilience with 107 Gain Tests Key Resistance Spero Therapeutics SPRO Jumps 49 as Stock Approaches Key Resistance at 315